logo-large
  • Browse Categories

Publications by authors named "Emma Minihane"

Claim this Profile
S
Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma.
Lyndsey Flanagan, Aisling Coughlan, Nicola Cosgrove, Andrew Roe, Yu Wang, Emma Minihane

Haematologica· September 2024


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-Mechanism ERK1/2 Inhibitors Exploit a Distinct Binding Mode to Block Phosphorylation and Nuclear Accumulation of ERK1/2.
Andrew M Kidger, Joanne M Munck, Harpreet K Saini, Kathryn Balmanno, Emma Minihane

Mol Cancer Ther· February 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors.
Matthew J Sale, Emma Minihane, Noel R Monks, Rebecca Gilley, Frances M Richards

Nat Commun· November 2019


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: